Skip to content

Dr. M. Vanheeswyck

Active
Private limited companyfounded 2021active for 4 yearsKerkhofstraat 42, 3500 Hasselt, BelgiumKBO/BCE: BE 0776.749.175

From the official registers: KBO 4 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. M. Vanheeswyck has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €40,526 and a net result of €74,715. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 19% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 02-11-2021 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.323.725.466 3500 Hasselt, since 02-11-2021
Financial year end
31 December
Peppol
Reachable since 26-07-2024

Board and ownership

Board
  • VANHEESWYCK MATISSEDirector

Financial position

92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€106,310
▲ 18.1%
Turnover
≈ €190,000
estimated
Profit
€74,715
▲ 26.5%
Equity
€40,526
▼ 77.2%
Total assets
€221,670
▲ 10.8%
Filed on 28-05-2026, 64 days before the deadlinePDF
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.10, cash €168,221Size: total assets €221,670Figures for financial year 2025 (filed on 29-05-2026)Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 34% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 43-57
equity 18.3% of total assets
Liquidity 55-45
short-term debt 81.7% · cash 75.9%
Profitability 100=
return on assets 33.7%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026highest value 10-2026: < 0.1%● unchanged vs 09-2026highest value 11-2026: < 0.1%● unchanged vs 10-2026highest value
Credit of up to €3,500 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.1 (8.5 in 2024), below the usual 1.5. Short-term debt is 81.7% and cash 75.9% of total assets. 81.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 19% of them on solvency, 31% on liquidity, 80% on profitability and 8% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.10, cash €168,221
NBB · annual accounts
lowers risk · Size: total assets €221,670
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 29-05-2026)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 20678 sector peers (2025).
NBB · sector comparison
Position among 20678 sector peers
Solvency
better than 19%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-05-2026, 64 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
64 days early
2024
36 days early
2023
35 days early
2022
39 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 4 accounts on average 44 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 24 June (4 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Equity fell in 2025from €177,811 to €40,526 ▼ 77.2% View
  • Caution: Lower solvency than 81% of companies in human healthsector median 63.0% · 20,678 companies 18.3% View
  • Positive: Always filed on timeaccounts within the deadline every year 4 years View

Comparable companies

These companies have the same main activity as Dr. M. Vanheeswyck: general medical practice (NACE 86210). They are comparable in size and age: total assets between €207,000 and €239,000, founded between 2020 and 2022.

CompanyTotal assetsGross margin
Dr. M. Vanheeswyck Hasselt€221,670€106,310
Dr. Kathleen Dreesen Zonhoven€231,685€110,281
Dokter Leyssen Riet Oudsbergen€218,695€103,725
DR. LIESBETH SCHUERMANS Lummen€234,923€97,147
Fournier Thomas MedGen Eghezée€222,566€101,545
Dokter Oelbrandt Lore Mechelen€207,318€102,890
Lisa Van Eyck Ravels€238,620€109,127
Full comparison

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Dr. M. Vanheeswyck

What is the company number of Dr. M. Vanheeswyck?
The company number of Dr. M. Vanheeswyck is 0776.749.175. The VAT number is the same number with BE in front: BE 0776.749.175.
Where is Dr. M. Vanheeswyck based?
The registered office is at Kerkhofstraat 42, 3500 Hasselt.Company details
What does Dr. M. Vanheeswyck do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. M. Vanheeswyck?
The legal form of Dr. M. Vanheeswyck is Private limited company (BV).
When was Dr. M. Vanheeswyck founded?
Dr. M. Vanheeswyck was founded on 02-11-2021.
Is Dr. M. Vanheeswyck still active?
Yes, Dr. M. Vanheeswyck is an active enterprise in the KBO register.
What is the turnover of Dr. M. Vanheeswyck?
The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €106,310 and 30 comparable companies (NACE 86210). It probably lies between €150,000 and €240,000.Financials
Is Dr. M. Vanheeswyck profitable?
In financial year 2025, Dr. M. Vanheeswyck made a profit of €74,715.
Where can I find the annual accounts of Dr. M. Vanheeswyck?
Dr. M. Vanheeswyck filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of Dr. M. Vanheeswyck due?
Dr. M. Vanheeswyck must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.